Shape effect in the design of nanowire-coated microparticles as transepithelial drug delivery devices.

While the oral drug delivery route has traditionally been the most popular among patients, it is estimated that 90% of therapeutic compounds possess oral bioavailability limitations. Thus, the development of novel drug carriers for more effective oral delivery of therapeutics is an important goal. Composite particles made by growing nanoscopic silicon wires from the surface of narrowly dispersed, microsized silica beads were previously shown to be able to (a) adhere well onto the epithelium by interdigitating their nanowires with the apical microvilli and (b) increase the permeability of Caco-2 cell monolayers with respect to small organic molecules in direct proportion to their concentration. A comparison between the effects of spherical and planar particle morphologies on the permeability of the epithelial cell layer in vitro and in vivo presented the subject of this study. Owing to their larger surface area, the planar particles exhibited a higher drug-loading efficiency than their spherical counterparts, while simultaneously increasing the transepithelial permeation of a moderately sized model drug, insulin. The insulin elution profile for planar nanowire-coated particles displayed a continual increase in the cumulative amount of the released drug, approaching a constant release rate for a 1-4 h period of the elution time. An immunohistochemical study confirmed the ability of planar silica particles coated with nanowires to loosen the tight junction of the epithelial cells to a greater extent than the spherical particles did, thus, enabling a more facile transport of the drug across the epithelium. Transepithelial permeability tests conducted for model drugs ranging in size from 0.4 to 150 kDa yielded three categories of molecules depending on their permeation propensities. Insulin belonged to the category of molecules deliverable across the epithelium only with the assistance of nanowire-coated particles. Other groups of drugs, smaller and bigger, respectively, either did not need the carrier to permeate the epithelium or were not able to cross it even with the support from the nanowire-coated particles. Bioavailability of insulin orally administered to rabbits was also found to be increased when delivered in conjunction with the nanowire-coated planar particles.

[1]  S. Tanabe,et al.  The casein peptide Asn-Pro-Trp-Asp-Gln enforces the intestinal tight junction partly by increasing occludin expression in Caco-2 cells , 2010, British Journal of Nutrition.

[2]  P. Claude Morphological factors influencing transepithelial permeability: A model for the resistance of theZonula Occludens , 1978, The Journal of Membrane Biology.

[3]  C. Weber,et al.  Tight junction pore and leak pathways: a dynamic duo. , 2011, Annual review of physiology.

[4]  Hsing-Wen Sung,et al.  Mechanism and consequence of chitosan-mediated reversible epithelial tight junction opening. , 2011, Biomaterials.

[5]  C. Lehr,et al.  Propidium iodide labeling of nanoparticles as a novel tool for the quantification of cellular binding and uptake. , 2011, Nanomedicine : nanotechnology, biology, and medicine.

[6]  Mauro Ferrari,et al.  Rapid tumoritropic accumulation of systemically injected plateloid particles and their biodistribution. , 2012, Journal of controlled release : official journal of the Controlled Release Society.

[7]  H. Santos,et al.  Drug permeation across intestinal epithelial cells using porous silicon nanoparticles. , 2011, Biomaterials.

[8]  C. Weber,et al.  MLCK-dependent exchange and actin binding region-dependent anchoring of ZO-1 regulate tight junction barrier function , 2010, Proceedings of the National Academy of Sciences.

[9]  Tejal A Desai,et al.  Microtextured substrata alter gene expression, protein localization and the shape of cardiac myocytes. , 2003, Biomaterials.

[10]  Thomas J. Raub,et al.  Characterization of the human colon carcinoma cell line (Caco-2) as a model system for intestinal epithelial permeability. , 1989, Gastroenterology.

[11]  Tejal A Desai,et al.  Gastrointestinal patch systems for oral drug delivery. , 2005, Drug discovery today.

[12]  T. Desai,et al.  Hierarchical nanoengineered surfaces for enhanced cytoadhesion and drug delivery. , 2011, Biomaterials.

[13]  B. Powell,et al.  Rapid disruption of intestinal barrier function by gliadin involves altered expression of apical junctional proteins , 2005, FEBS letters.

[14]  Thomas Kissel,et al.  Do cell culture conditions influence the carrier-mediated transport of peptides in Caco-2 cell monolayers? , 2003, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[15]  K. Yagi,et al.  Peptides as tight junction modulators. , 2011, Current pharmaceutical design.

[16]  T. Desai,et al.  Microfabricated drug delivery systems: from particles to pores. , 2003, Advanced drug delivery reviews.

[17]  J. Madara,et al.  Partitioning of paracellular conductance along the ileal crypt-villus axis: A hypothesis based on structural analysis with detailed consideration of tight junction structure-function relationships , 2005, The Journal of Membrane Biology.

[18]  T. Desai,et al.  Nanoengineered surfaces enhance drug loading and adhesion. , 2011, Nano letters.

[19]  Jin-jin Fan,et al.  Altered tight junctions and fence function in NRK-52E cells induced by aristolochic acid , 2012, Human & experimental toxicology.

[20]  Tejal A Desai,et al.  Biomimetic nanowire coatings for next generation adhesive drug delivery systems. , 2009, Nano letters.

[21]  Deying Cao,et al.  Preparation and characterization of insulin-loaded bioadhesive PLGA nanoparticles for oral administration. , 2012, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[22]  F. Veiga,et al.  Oral administration of peptides and proteins: nanoparticles and cyclodextrins as biocompatible delivery systems. , 2007, Nanomedicine.

[23]  Tejal A Desai,et al.  Contractility-dependent modulation of cell proliferation and adhesion by microscale topographical cues. , 2008, Small.

[24]  T. Kissel,et al.  Variation of peptide transporter (PepT1 and HPT1) expression in Caco-2 cells as a function of cell origin. , 2004, Journal of pharmaceutical sciences.

[25]  Mauro Ferrari,et al.  Design of bio-mimetic particles with enhanced vascular interaction. , 2009, Journal of biomechanics.

[26]  J. Morris,et al.  Macrophages increase microparticle uptake by enterocyte‐like Caco‐2 cell monolayers , 2010, Journal of anatomy.

[27]  P. Augustijns,et al.  Biological, pharmaceutical, and analytical considerations with respect to the transport media used in the absorption screening system, Caco-2. , 2003, Journal of pharmaceutical sciences.

[28]  R. Rao,et al.  Tyrosine phosphorylation and dissociation of occludin-ZO-1 and E-cadherin-beta-catenin complexes from the cytoskeleton by oxidative stress. , 2002, The Biochemical journal.

[29]  P. Artursson,et al.  Correlation between oral drug absorption in humans and apparent drug permeability coefficients in human intestinal epithelial (Caco-2) cells. , 1991, Biochemical and biophysical research communications.

[30]  V. Uskoković Composites comprising cholesterol and carboxymethyl cellulose. , 2008, Colloids and surfaces. B, Biointerfaces.

[31]  T. Orfeo,et al.  One hundred and twenty-seven cultured human tumor cell lines producing tumors in nude mice. , 1977, Journal of the National Cancer Institute.

[32]  H. Costantino,et al.  Discovery of tight junction modulators: significance for drug development and delivery. , 2008, Drug discovery today.

[33]  A. Basit Advances in Colonic Drug Delivery , 2012, Drugs.

[34]  Desirée Teijeiro-Osorio,et al.  New generation of hybrid poly/oligosaccharide nanoparticles as carriers for the nasal delivery of macromolecules. , 2009, Biomacromolecules.

[35]  S. O'Sullivan,et al.  Pharmacological Effects of Cannabinoids on the Caco-2 Cell Culture Model of Intestinal Permeability , 2010, Journal of Pharmacology and Experimental Therapeutics.

[36]  Tejal A Desai,et al.  PEGylated silicon nanowire coated silica microparticles for drug delivery across intestinal epithelium. , 2012, Biomaterials.

[37]  Kristy M Ainslie,et al.  In vitro immunogenicity of silicon-based micro- and nanostructured surfaces. , 2008, ACS nano.

[38]  Yahya E Choonara,et al.  Diverse approaches for the enhancement of oral drug bioavailability , 2011, Biopharmaceutics & drug disposition.

[39]  V. Uskoković Insights into morphological nature of precipitation of cholesterol , 2008, Steroids.

[40]  S. Chong,et al.  Cell culture-based models for intestinal permeability: a critique. , 2005, Drug discovery today.

[41]  Mauro Ferrari,et al.  Intravascular Delivery of Particulate Systems: Does Geometry Really Matter? , 2008, Pharmaceutical Research.

[42]  Hsing-Wen Sung,et al.  A review of the prospects for polymeric nanoparticle platforms in oral insulin delivery. , 2011, Biomaterials.